DiabetologiaJClub
Non-pharmacological treatment of MASLD.
Diabetologia · · Review · Open access
Dufour, Berzigotti
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
Lifestyle interventions for metabolic dysfunction-associated steatotic liver disease (MASLD) improve outcomes, with even modest weight loss beneficial and exercise linked to dose-dependent reductions in steatosis, fibrosis, and hepatocellular carcinoma risk.
- Why it matters: MASLD is driven by modifiable lifestyle patterns, and effective non-drug strategies could improve liver fat while also strengthening cardiometabolic health beyond the liver.
- What they did: The review synthesizes evidence that weight loss is the cornerstone, achieved via energy restriction plus physical activity/exercise, and it highlights detrimental roles of diet quality, sedentary behavior, and sleep/circadian disruption.
- The result: Despite strong efficacy, real-world implementation is difficult with suboptimal long-term adherence, and individual variability motivates biomarker research for more personalized approaches.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
- 1 cites
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.